(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): | |||||
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | ||
Emerging Growth Company | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
HAEMONETICS CORPORATION | ||||||||||||||
June 29, 2020 | By: | /s/ Christopher A. Simon | ||||||||||||
Name: | Christopher A. Simon | |||||||||||||
Title: | President and Chief Executive Officer | |||||||||||||
Document and Entity Information |
Jun. 29, 2020 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Jun. 29, 2020 |
Entity Registrant Name | HAEMONETICS CORPORATION |
Entity Central Index Key | 0000313143 |
Amendment Flag | false |
Entity Incorporation, State or Country Code | MA |
Entity File Number | 001-14041 |
Entity Tax Identification Number | 04-2882273 |
Entity Address, Address Line One | 125 Summer Street |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02110 |
City Area Code | 781 |
Local Phone Number | 848-7100 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, $.01 par value per share |
Trading Symbol | HAE |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |
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end